Back to HALO
D. E. Shaw & Co., Inc. HALO Position History
Halozyme Therapeutics, Inc. • Healthcare
Quarters held
25
Latest value
$148.6M
Q2 2026
Peak value
$176.7M
First seen
Q2 2022
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q2 2022 | $1.1M |
| Q3 2022 | $1.1M |
| Q4 2022 | $1.7M |
| Q4 2023 | $945K |
| Q1 2024 | $12.1M |
| Q2 2024 | $25.1M |
| Q3 2024 | $17.6M |
| Q4 2024 | $1.1M |
| Q4 2024 | $38.7M |
| Q1 2025 | $32.2M |
| Q1 2025 | $7.3M |
| Q2 2025 | $7M |
| Q2 2025 | $46M |
| Q3 2025 | $17.7M |
| Q3 2025 | $176.7M |
| Q4 2025 | $5.3M |
| Q4 2025 | $105.8M |
| Q1 2026 | $5.5M |
| Q1 2026 | $633K |
| Q1 2026 | $1.4M |
| Q1 2026 | $115.2M |
| Q2 2026 | $8.4M |
| Q2 2026 | $767K |
| Q2 2026 | $2.2M |
| Q2 2026 | $148.6M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q2 2026 | $148.6M | 1.90M | — | — |
| Q2 2026 | $2.2M | 28.2K | — | — |
| Q2 2026 | $767K | 9.8K | — | — |
| Q2 2026 | $8.4M | 107.4K | — | — |
| Q1 2026 | $115.2M | 1.78M | — | — |
| Q1 2026 | $1.4M | 20.9K | — | — |
| Q1 2026 | $633K | 9.8K | — | — |
| Q1 2026 | $5.5M | 85.7K | — | — |
| Q4 2025 | $105.8M | 1.57M | — | — |
| Q4 2025 | $5.3M | 78.1K | — | — |
| Q3 2025 | $176.7M | 2.41M | — | — |
| Q3 2025 | $17.7M | 241.2K | — | — |
| Q2 2025 | $46M | 883.8K | — | — |
| Q2 2025 | $7M | 135.0K | — | — |
| Q1 2025 | $7.3M | 114.3K | — | — |
| Q1 2025 | $32.2M | 505.3K | — | — |
| Q4 2024 | $38.7M | 809.0K | — | — |
| Q4 2024 | $1.1M | 22.4K | — | — |
| Q3 2024 | $17.6M | 306.6K | — | — |
| Q2 2024 | $25.1M | 478.8K | — | — |
| Q1 2024 | $12.1M | 298.1K | — | — |
| Q4 2023 | $945K | 25.6K | — | — |
| Q4 2022 | $1.7M | 30.4K | — | — |
| Q3 2022 | $1.1M | 27.0K | — | — |
| Q2 2022 | $1.1M | 24.1K | — | — |
Other funds holding HALO
$545.3M
$405.4M
$405.4M
$319.1M
$251.9M
$236.6M